ClinicalTrials.gg
Drug

Brexpiprazole clinical trials

Also written OPC-34712 and Rexulti.

studies test it
79
open now
4
in phase 3
49
first study started
2008

How each study uses brexpiprazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the brexpiprazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Jul 2015 · REXULTI · NDA 205422 (FDA, Drugs@FDA)
European Union
26 Jul 2018 · Rxulti · EMEA/H/C/003841 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Brexpiprazole
56
Brexpiprazole (OPC-34712)
2
Brex
2
Brexpiprazole, OPC-34712
2

Brand

Rexulti
12

Development codes

OPC-34712
27
LuAF41156
1
OPC-331
1

In one entry with another drug

Given together, or one or the other

OPC-34712 + ADT
2

Studies by the year they started

79 studies that test it; most in 2013 (15)

Studies that test brexpiprazole, by start year
YearStudies
20081
20094
20103
20119
20123
201315
20143
20152
20162
201710
201810
20198
20203
20212
20221
20231
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
15
Phase 3
49
Phase 4
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 69 · Other 10

Otsuka Pharmaceutical Development & Commercialization, Inc. (48) · H. Lundbeck A/S (9) · Otsuka Pharmaceutical Co., Ltd. (7) · Otsuka Beijing Research Institute (4) · Humanis Saglık Anonim Sirketi (1) · University of Massachusetts, Worcester (1) · University Health Network, Toronto (1) · University of Chicago (1)

Often tested with

Tested in the same studies.

Sertraline (3) · Antiandrogens (3) · Escitalopram (1) · Aripiprazole (1) · Moxifloxacin (1) · Cariprazine (1) · Risperidone (1)

Studies

Open first, then newest update. How each study uses brexpiprazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 79

See all 79 studies that test brexpiprazole →

Given beside what is tested · 3 — brexpiprazole is usual care or a partner of the new treatment

Codes

What other systems call brexpiprazole · ClinicalTrials.gg INT000076

  • MeSH (NLM) C000591922brexpiprazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 2J3YBM1K8CBREXPIPRAZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 1658314Confirmed FDA, Wikidata
  • Wikidata Q2924764brexpiprazoleConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166575BrexpiprazoleOne source FDA
  • DrugBank DB09128One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.